Literature DB >> 30100137

Defining Treatment Success After 2-Stage Exchange Arthroplasty for Periprosthetic Joint Infection.

Timothy L Tan1, Karan Goswami1, Yale A Fillingham1, Noam Shohat2, Alexander J Rondon1, Javad Parvizi1.   

Abstract

BACKGROUND: Two-stage exchange arthroplasty remains the preferred surgical treatment method for patients with chronic periprosthetic joint infection (PJI). The success of this procedure is not known exactly as various definitions of success have been used. This study aimed at analyzing the difference in outcome following 2-stage exchange arthroplasty using different definitions for success.
METHODS: A retrospective study of 703 patients with PJI who underwent resection arthroplasty and spacer insertion between January 1999 and June 2015 was performed. Chart review identified intraoperative cultures at the time of spacer, reimplantation, and any subsequent reinfections or surgeries following spacer insertion. After applying the exclusion criteria, a total of 570 patients were included in the analysis. Five definitions of treatment success were assessed: (1) Delphi consensus success, (2) modified Delphi consensus success, (3) microbiological success, (4) implant success, and (5) surgical success.
RESULTS: Of the 570 patients with PJIs, 458 were reimplanted at a mean of 4.1 months. Mortality was 13.9% with 6.7% occurring before reimplantation. Treatment success was highly variable depending on the definition used (54.2%-88.9%). In 19.6% of PJI cases, the Delphi consensus definition could not be assessed as reimplantation never occurred. Furthermore, 67.0% of these patients underwent reoperations, which may not be accounted for in the Delphi consensus definition.
CONCLUSION: Treatment success rates vary dramatically depending on the definition used at our institution. We hope these definitions can help bring forth awareness for standardized reporting of outcomes, but further validation and agreement of these definitions among surgeons and infectious disease physicians is crucial.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  exchange arthroplasty; hip; knee; outcomes; periprosthetic joint infection; treatment success

Mesh:

Year:  2018        PMID: 30100137     DOI: 10.1016/j.arth.2018.06.015

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  7 in total

1.  Do Serum C-Reactive Protein Trends Predict Treatment Outcome in Patients with Knee Periprosthetic Joint Infection Undergoing Two-Stage Exchange Arthroplasty?

Authors:  Sheng-Hsun Lee; Chun-Ting Chu; Chih-Hsiang Chang; Chih-Chien Hu; Szu-Yuan Chen; Tung-Wu Lu; Yu-Chih Lin
Journal:  Diagnostics (Basel)       Date:  2022-04-20

2.  Changes in serum markers failed to predict persistent infection after two-stage exchange arthroplasty.

Authors:  Qiao Jiang; Jun Fu; Wei Chai; Li-Bo Hao; Yong-Gang Zhou; Chi Xu; Ji-Ying Chen
Journal:  J Orthop Surg Res       Date:  2020-09-04       Impact factor: 2.359

3.  Predictors of Treatment Failure for Hip and Knee Prosthetic Joint Infections in the Setting of 1- and 2-Stage Exchange Arthroplasty: A Multicenter Retrospective Cohort.

Authors:  Christopher E Kandel; Richard Jenkinson; Nick Daneman; David Backstein; Bettina E Hansen; Matthew P Muller; Kevin C Katz; Jessica Widdifield; Earl Bogoch; Sarah Ward; Abhilash Sajja; Felipe Garcia Jeldes; Allison McGeer
Journal:  Open Forum Infect Dis       Date:  2019-10-21       Impact factor: 3.835

Review 4.  PMMA-Based Bone Cements and the Problem of Joint Arthroplasty Infections: Status and New Perspectives.

Authors:  Alessandro Bistolfi; Riccardo Ferracini; Carlo Albanese; Enrica Vernè; Marta Miola
Journal:  Materials (Basel)       Date:  2019-12-02       Impact factor: 3.623

5.  Two-stage exchange Arthroplasty is a viable treatment for Periprosthetic joint infection in inflammatory diseases.

Authors:  Qiao Jiang; Jun Fu; Wei Chai; Li-Bo Hao; Yong-Gang Zhou; Chi Xu; Ji-Ying Chen
Journal:  BMC Musculoskelet Disord       Date:  2020-10-14       Impact factor: 2.362

6.  The role of fibrinogen in predicting reinfection after DAIR for periprosthetic joint infections.

Authors:  Dacheng Zhao; Jinwen He; Xingwen Wang; Xiaobing Zhao; Yayi Xia; Bin Geng
Journal:  BMC Musculoskelet Disord       Date:  2021-05-24       Impact factor: 2.362

7.  Periprosthetic Joint Infection (PJI)-Results of One-Stage Revision with Antibiotic-Impregnated Cancellous Allograft Bone-A Retrospective Cohort Study.

Authors:  Gregor Dersch; Heinz Winkler
Journal:  Antibiotics (Basel)       Date:  2022-02-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.